Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3279845

Documents

Beta release

Statistics of Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
Statistics for this year
PeriodVisitsDownloads
20241010
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0633
2024-0711
2024-0800